Varietal description of two genotypes of manzano chili pepper (Capsicum pubescens Ruiz & Pav.)

Objective: the objective of this research work was to obtain the varietal description of two varieties of chile manzano in Las Montañas in the center of Veracruz, México. Design/methodology/approach: the varietal characterization module was established under greenhouse conditions at the Centro de Bachillerato Tecnológico Agropecuario No. 99 in the municipality of Coscomatepec de Bravo. The recorded descriptors were in accordance with the International of Plant Genetic Resources Institute for Capsicum and the Graphic Handbook for Variety Description of manzano hot pepper. The plants were characterized from the seedling to the adult plant. The agronomic management of the crop was carried out in accordance with the manual for the production of manzano hot pepper in Las Montañas of the state of Veracruz. Results: all qualitative descriptors were constant for the two varieties MEXUVNE1-15-C2 and MEXUVCU1-16-C2 from seedling to fruiting; in contrast, there were dissimilarities in plant height, stem, leaf, flower, fruit and seed dimensions. Limitations of the study/implications: the pandemic caused by COVID-19 was the main limitation so that some descriptors were not recorded in a timely manner as indicated in the Graphic Handbook. Findings/conclusions: both varieties are very similar; however, the greatest distinction was in the quantitative type descriptors such as: plant height, fruit length, fruit diameter and number of seeds.Objective: The objective of this research study was to obtain the varietal description of two varieties of manzano chili pepper in Las Montañas region, in central Veracruz, Mexico. Design/methodology/approach: The varietal characterization module was established under greenhouse conditions. The markers recorded were in accordance with the International Plant Genetic Resources Institute for Capsicum and the Graphic Handbook for Variety Description of manzano chili pepper. The plants were characterized from seedling in greenhouse to adult plant. The agronomic management of the crop was carried out in accordance with the manual for the production of manzano chili pepper in Las Montañas, state of Veracruz. Results: All qualitative markers were constant for the two varieties, MEXUVNE1-15-C2 and MEXUVCU1-16-C2, from seedling to fruit setting. In contrast, there were dissimilarities in plant height, and stem, leaf, flower, fruit and seed dimensions. Study limitations/implications: The pandemic caused by COVID-19 was the main limitation, resulting in some markers not being recorded in a timely manner as indicated in the Graphic Handbook. Findings/conclusions: Both varieties are very similar; however, the greatest distinction was in the quantitative markers, such as: plant height, fruit length, fruit diameter and number of seeds

Nurses' perceptions of aids and obstacles to the provision of optimal end of life care in ICU

Contains fulltext : 172380.pdf (publisher's version ) (Open Access

Triboelectric Energy Harvester Based on Stainless Steel/MoS2 and PET/ITO/PDMS for Potential Smart Healthcare Devices

The smart healthcare devices connected with the internet of things (IoT) for medical services can obtain physiological data of risk patients and communicate these data in real-time to doctors and hospitals. These devices require power sources with a sufficient lifetime to supply them energy, limiting the conventional electrochemical batteries. Additionally, these batteries may contain toxic materials that damage the health of patients and environment. An alternative solution to gradually substitute these electrochemical batteries is the development of triboelectric energy harvesters (TEHs), which can convert the kinetic energy of ambient into electrical energy. Here, we present the fabrication of a TEH formed by a stainless steel substrate (25 mm × 15 mm) coated with a molybdenum disulfide (MoS2) film as top element and a polydimethylsiloxane (PDMS) film deposited on indium tin oxide coated polyethylene terephthalate substrate (PET/ITO). This TEH has a generated maximum voltage of 2.3 V and maximum output power of 112.55 μW using a load resistance of 47 kΩ and a mechanical vibration to 59.7 Hz. The proposed TEH could be used to power potential smart healthcare devices

Treatment satisfaction, patient preferences, and the impact of suboptimal disease control in a large international rheumatoid arthritis cohort: SENSE study

Background: Patients’ needs and perspectives are important determinants of treatment success in rheumatoid arthritis (RA). Assessing patients’ perspectives can help identify unmet needs and enhance the understanding of treatment benefits. Objectives: The SENSE study assessed the impact of inadequate response to disease-modifying antirheumatic drugs (DMARDs) on treatment satisfaction, disease outcomes, and patient perspectives related to RA disease management. Methods: SENSE was a noninterventional, cross-sectional study conducted in 18 countries across Europe, Asia, and South America. Adult patients with poorly controlled RA of moderate/high disease activity were eligible. Patient satisfaction was assessed by the Treatment Satisfaction Questionnaire for Medication (TSQM v1.4). Treatment adherence, healthcare resource utilization (HRU), quality of life (QoL), work ability, digital health literacy (DHL), patient preference information, and treatment strategy were also assessed. Results: 1,624 patients were included in the study: most were female (84.2%) and middle-aged, and mean disease duration was 10.5 years. Mean TSQM global satisfaction subscore was 60.9, with only 13.5% of patients reporting good treatment satisfaction (TSQM global ≥80). The strongest predictor of good treatment satisfaction was treatment with advanced therapies. Most patients (87.4%) reported good treatment adherence. In general, patients had impaired QoL and work ability, high HRU, and 67.4% had poor DHL. Leading treatment expectations were “general improvement of arthritis” and “less joint pain”. Most patients preferred oral RA medications (60.7%) and rapid (≤1 week) onset of action (71.1%). “Increased risk for malignancies” and “increased risk for cardiovascular disease” were the least acceptable side effects. Despite suboptimal control, advanced therapies were only used in a minority of patients, and DMARD switches were planned for only half of the patients. Conclusion: Suboptimal disease control negatively impacts treatment satisfaction, work ability, QoL, and HRU. Data collected on patient perspectives may inform shared decision-making and optimize treat-to-target strategies for improving patient outcomes in RA.</p

ESICM LIVES 2016: part two : Milan, Italy. 1-5 October 2016.

Meeting abstrac